Genetic architecture of Alzheimer's disease-related plasma biomarkers
Aaltonen, A.; Palviainen, T.; Heikkinen, S.; Herukka, S.-K.; Hiltunen, M.; Kokkola, T.; Karkkainen, S.; FinnGen, ; Palotie, A.; Runz, H.; Julkunen, V.; Kaprio, J.; Saari, T.; Vuoksimaa, E.
Show abstract
INTRODUCTIONAlzheimers disease-related plasma biomarker interrelationships and factors underlying these associations remain poorly understood. To address this, we studied the heritability of plasma biomarkers and their associations with cognition. METHODSThis study included 696 twins, aged 65-85, without a diagnosis of Alzheimers disease. Plasma amyloid beta 42 and 40, phosphorylated tau (p-tau) 181 and 217, neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) were quantified with Simoa HD-X, and cognition was assessed with cCOG. Statistical analyses were done with multivariate twin models and linear mixed effect models. RESULTSPhenotypic associations between p-tau181, p-tau217, NfL and GFAP were 0.22-0.73. Heritability estimates were 0.39-0.66, and genetic correlations were 0.32-0.67. P-tau181 and p-tau217 were associated with cognition ({beta} = -0.12; 95% CI: -0.19--0.04 and {beta} = -0.19; 95% CI: -0.26--0.12, respectively). DISCUSSIONThe observed phenotypic and genetic associations highlight shared underlying mechanisms among plasma biomarkers.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Effect of Pathway-specific Polygenic Risk Scores for Alzheimer’s Disease (AD) on Rate of Change in Cognitive Function and AD-related Biomarkers among Asymptomatic Individuals 97%
- CSF sphingomyelins in Alzheimer’s disease, neurodegeneration, and neuroinflammation 95%
- Liver-specific polygenic risk score is more strongly associated than genome-wide score with Alzheimer’s disease diagnosis in a case-control analysis 94%
Similar papers in this journal
- Obesity-related brain atrophy occurs through mechanisms independent of Alzheimer’s disease pathology 94%
- A residual marker of cognitive reserve is associated with resting-state intrinsic functional connectivity along the Alzheimer’s disease continuum 94%
- An X Chromosome Transcriptome Wide Association Study Implicates ARMCX6 in Alzheimer's Disease 94%
Similar papers in this journal
- Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer’s disease 94%
- Integrative Brain Transcriptome Analysis Links Complement Component 4 and HSPA2 to the APOE ε2 Protective Effect in Alzheimer Disease 94%
- Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease 93%
Similar papers in this journal
- Polygenic effects on the risk of Alzheimer’s disease in the Japanese population 95%
- Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohort 94%
- Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer’s disease 94%